Heparin-Induced Thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis …

Background Heparin-induced thrombocytopenia (HIT) is a rare complication of heparin
treatments, and only a few large patient cohorts have been reported. In this study, biological …

Heparin-induced thrombocytopenia (HIT) is an immune reaction in response to platelet
factor 4-heparin complexes, which results in increased platelet activation and …

Purpose All physicians who use heparin should be aware of immune heparin-induced
thrombocytopenia (HIT), including anesthesiologists who may need to provide intraoperative …

Heparin-induced thrombocytopenia (HIT) is a serious, prothrombotic, immune-mediated
complication of heparin therapy that can cause limb-and life-threatening thromboembolic …

Heparin-induced thrombocytopenia (HIT) is associated with clinically significant morbidity
and mortality. Patients who are critically ill are commonly thrombocytopenic and exposed to …

Heparin-induced thrombocytopenia (HIT) is a drug-induced, immunoglobulin-mediated
thrombocytopenic disorder that is important for at least three reasons. First, it is a relatively …

Heparin-induced thrombocytopenia (HIT) is a major health problem, especially in cardiac
surgery theaters, cardiac catheterization labs, and intensive care units. Some patients with …

Heparin-induced thrombocytopenia (HIT) is a drug-mediated, prothrombotic disorder caused
by immunization against platelet factor 4 (PF4) after complex formation with heparin or other …

Background: Thrombocytopenia is a common occurrence in critical illness, reported in up to
41% of patients. Systematic evaluation of thrombocytopenia in critical care is essential to …